X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (6119) 6119
Newsletter (545) 545
Newspaper Article (198) 198
Book Chapter (36) 36
Magazine Article (29) 29
Transcript (23) 23
Dissertation (4) 4
Publication (3) 3
Conference Proceeding (2) 2
Book Review (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
ipilimumab (6278) 6278
immunotherapy (3452) 3452
humans (3242) 3242
oncology (3190) 3190
melanoma (3027) 3027
cancer (2230) 2230
nivolumab (2001) 2001
male (1386) 1386
metastasis (1314) 1314
care and treatment (1282) 1282
pembrolizumab (1268) 1268
female (1255) 1255
melanoma - drug therapy (1235) 1235
metastatic melanoma (1217) 1217
middle aged (1115) 1115
antibodies, monoclonal - therapeutic use (1069) 1069
survival (1046) 1046
immunology (993) 993
chemotherapy (975) 975
aged (950) 950
research (901) 901
open-label (862) 862
patients (776) 776
therapy (719) 719
tumors (719) 719
drug therapy (707) 707
adult (704) 704
melanoma - pathology (689) 689
antibodies, monoclonal - adverse effects (665) 665
safety (662) 662
treatment outcome (654) 654
immune checkpoint (644) 644
antineoplastic agents - therapeutic use (634) 634
immunotherapy - methods (614) 614
clinical trials (613) 613
cancer therapies (609) 609
skin neoplasms - drug therapy (607) 607
pd-1 (585) 585
lymphocytes (558) 558
blockade (543) 543
ctla-4 (525) 525
adverse events (516) 516
advanced melanoma (509) 509
medicine, research & experimental (502) 502
programmed cell death 1 receptor - antagonists & inhibitors (488) 488
metastases (487) 487
analysis (476) 476
animals (463) 463
melanoma - immunology (463) 463
skin neoplasms - pathology (454) 454
prognosis (453) 453
lung cancer (441) 441
aged, 80 and over (436) 436
apoptosis (436) 436
medical research (428) 428
dermatology (427) 427
multicenter (427) 427
ctla-4 antigen - antagonists & inhibitors (426) 426
antigens (424) 424
health aspects (418) 418
immune checkpoint inhibitors (401) 401
double-blind (394) 394
melanoma - therapy (393) 393
t cells (390) 390
antineoplastic agents - adverse effects (375) 375
expression (373) 373
cytotoxicity (367) 367
antineoplastic agents, immunological - therapeutic use (364) 364
mutation (364) 364
t-cells (363) 363
vemurafenib (361) 361
neoplasms - immunology (358) 358
neoplasms - drug therapy (351) 351
biomarkers (348) 348
cell lung-cancer (342) 342
medicine & public health (342) 342
antibodies (341) 341
toxicity (340) 340
monoclonal antibodies (338) 338
antibodies, monoclonal - administration & dosage (336) 336
antibody (334) 334
complications and side effects (331) 331
pharmacology & pharmacy (330) 330
lymphocytes t (328) 328
melanoma - secondary (327) 327
ctla-4 antigen - immunology (323) 323
antineoplastic combined chemotherapy protocols - therapeutic use (322) 322
neoplasm staging (321) 321
medical prognosis (319) 319
usage (319) 319
review (317) 317
retrospective studies (315) 315
pd-1 protein (314) 314
antineoplastic agents, immunological - adverse effects (306) 306
pd-1 blockade (304) 304
ctla-4 blockade (303) 303
immune system (302) 302
skin cancer (296) 296
anti-pd-1 (295) 295
surgery (292) 292
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (6689) 6689
German (124) 124
French (122) 122
Japanese (24) 24
Spanish (22) 22
Russian (12) 12
Czech (11) 11
Chinese (7) 7
Danish (6) 6
Polish (6) 6
Portuguese (5) 5
Dutch (4) 4
Swedish (3) 3
Hungarian (2) 2
Korean (2) 2
Norwegian (2) 2
Hebrew (1) 1
Icelandic (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Research technology management, ISSN 0895-6308, 11/2019, Volume 62, Issue 6, p. 2
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2018, Volume 378, Issue 22, pp. 2093 - 2104
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2019, Volume 381, Issue 16, pp. 1535 - 1546
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2017, Volume 377, Issue 19, pp. 1824 - 1835
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2018, Volume 378, Issue 14, pp. 1277 - 1290
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2018, Volume 379, Issue 8, pp. 722 - 730
Journal Article
Journal of clinical oncology, ISSN 1527-7755, 2018, Volume 36, Issue 17, pp. 1668 - 1674
Purpose Pembrolizumab provides durable antitumor activity in metastatic melanoma, including complete response (CR) in about 15% of patients. Data are limited... 
CRITERIA | ONCOLOGY | NIVOLUMAB | IPILIMUMAB
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2019, Volume 381, Issue 21, pp. 2020 - 2031
Journal Article
Journal Article
Journal Article
Journal Article